Ray Blind
Department of Medicine
Division of Diabetes, Endocrinology & Metabolism
Department of Biochemistry
Department of Pharmacology
Vanderbilt Center for Structural Biology (CSB)
Vanderbilt Institute of Chemical Biology (VICB)
Vanderbilt-Ingram Cancer Center (VICC)
Vanderbilt Diabetes Research and Training Center (DRTC)
The Blind Lab uses structural biology, molecular genomics and chemical biology to discover new ways nuclear lipid signaling controls gene expression. We apply these discoveries to the design and implementation of novel drug screens, developing therapeutics for diabetes, cancer and fatty liver.
The Blind Lab uses structural biology, molecular genomics and chemical biology to discover new ways nuclear lipid signaling controls gene expression. We apply these discoveries to the design and implementation of novel drug screens, developing therapeutics for diabetes, cancer and fatty liver.
Keywords: Nuclear Lipid Signaling , Phospholipids , Structural Biology , Gene Expression , Genomics , Drug Design
Research Area: Structural Biology , Diabetes, Obesity, Metabolism , Gene Regulation , Genomics , Chemical Biology